# Pregnancy Termination: Clinical and Ethical Frameworks

## Introduction

Induced abortion is one of the most common procedures in reproductive healthcare, with approximately 930,000 abortions performed annually in the United States. Regardless of personal beliefs, obstetrician-gynecologists must understand the clinical management of abortion, associated complications, and the ethical principles governing patient care. Evidence-based, patient-centered abortion care is within the scope of comprehensive obstetric and gynecologic training.

## Epidemiology

The incidence is approximately 14.4 abortions per 1,000 women aged 15 to 44 in the United States based on 2020 data. By gestational age, 92.7% of abortions occur at or before 13 weeks, 6.2% at 14 to 20 weeks, and 1.1% at 21 weeks or later. Medication abortion now accounts for more than 50% of all abortions in the United States. Abortion is one of the safest medical procedures, with a mortality rate of 0.7 per 100,000 legal abortions. Risk increases with gestational age.

## First-Trimester Medication Abortion

### Regimen

The standard regimen is mifepristone 200 mg orally followed 24 to 48 hours later by misoprostol 800 mcg (administered buccally, vaginally, or sublingually). The efficacy is 95 to 98% complete abortion for pregnancies up to 70 days (10 weeks) gestation and 93 to 96% for 70 to 77 days. Mifepristone is a competitive progesterone receptor antagonist that destabilizes the decidua, softens the cervix, and sensitizes the myometrium to prostaglandins. Misoprostol is a prostaglandin E1 analogue that induces uterine contractions and cervical ripening.

### Clinical Protocol

The pre-procedure assessment confirms intrauterine pregnancy by ultrasound or clinical criteria, determines gestational age, obtains Rh type, and documents informed consent. Evidence supports no-test protocols in which medication abortion is provided without mandatory ultrasound when gestational age can be reliably determined by last menstrual period. Follow-up confirms completion by serum hCG decline (80% or greater decline at 7 to 14 days), ultrasound, or clinical assessment. Routine follow-up visits may not be necessary when telehealth follow-up is available. Contraception can be initiated immediately after confirmed completion, and LARC insertion can be planned at the follow-up visit.

### Contraindications

Absolute contraindications include ectopic pregnancy, chronic adrenal failure, concurrent long-term systemic corticosteroid therapy, known allergy to mifepristone or misoprostol, inherited porphyria, and IUD in situ (which must be removed before initiating). Relative contraindications include severe anemia, coagulopathy, and anticoagulant therapy.

## First-Trimester Procedural Abortion

### Uterine Aspiration

Vacuum aspiration is performed using a manual vacuum aspirator (MVA) or electric vacuum aspirator (EVA). Cervical preparation may not be needed before 9 weeks. For gestations of 9 weeks or later, misoprostol 400 mcg sublingual or buccal 1 to 3 hours prior is used, with osmotic dilators (laminaria) for the later first trimester. Anesthesia consists of a paracervical block with 1% lidocaine as standard, with moderate sedation or general anesthesia based on patient preference and facility capabilities. The procedure involves tenaculum placement on the cervix, sequential dilation if needed, insertion of an appropriately sized suction cannula (where the cannula size in mm approximates the gestational age in weeks), and systematic aspiration of the uterine cavity, followed by tissue inspection to confirm the presence of villi. The procedure typically takes 5 to 10 minutes. The efficacy exceeds 99% with a failure rate below 1%.

<image>Diagram of vacuum aspiration technique showing the suction cannula positioned within the uterine cavity with labeled structures including the cervix with tenaculum, dilated os, suction cannula, and direction of systematic aspiration from fundus to lower segment</image>

## Second-Trimester Abortion

### Dilation and Evacuation (D&E)

D&E is the preferred surgical method for second-trimester abortion, generally performed at 14 to 24 weeks. Cervical preparation is essential and involves osmotic dilators (laminaria or Dilapan-S) placed 1 to 2 days prior, with adjunctive misoprostol and/or mifepristone. Serial dilator placements may be needed for advanced gestations. The procedure uses ultrasound guidance, extraction forceps (Sopher, Bierer) in combination with suction, and systematic evacuation confirmed by ultrasound and tissue inspection. Anesthesia options include moderate sedation, regional, or general anesthesia. Complications include hemorrhage (1 to 4%), cervical laceration (less than 1%), uterine perforation (less than 0.5%), retained tissue, and infection.

### Induction Methods

Mifepristone 200 mg is given, followed 24 to 48 hours later by misoprostol using various dosing protocols depending on gestational age. Misoprostol alone can be administered at 400 mcg vaginally every 3 hours or 400 mcg sublingually every 3 hours. High-dose oxytocin protocols are used as an adjunct for later gestations. The mean time to delivery is 6 to 12 hours with mifepristone pretreatment and longer without.

## Complication Management

Hemorrhage is managed with uterotonic agents (methylergonovine, misoprostol, oxytocin), uterine balloon tamponade, or re-aspiration for retained tissue. Transfusion is rarely needed. Incomplete abortion is managed with re-aspiration, confirmed by ultrasound. Infection (endometritis) occurs in less than 1% of cases when prophylactic antibiotics are used (doxycycline 200 mg or azithromycin 500 mg pre-procedure) and is treated with broad-spectrum antibiotics. If uterine perforation is recognized, observation for hemodynamic stability is appropriate, with laparoscopy if bowel injury is suspected. Failed abortion is rare with procedural methods but more common with medication abortion at advanced gestations and is managed with aspiration.

## Ethical and Professional Frameworks

### Ethical Principles

Patient autonomy -- the patient's right to make informed decisions about her own reproductive health -- is a fundamental ethical principle. Beneficence and non-maleficence require providing safe, evidence-based care and avoiding harm through denial of care or imposition of unnecessary barriers. Justice demands equitable access to abortion services regardless of socioeconomic status, geography, race, or insurance coverage. Informed consent requires complete, unbiased information about all options (continuing pregnancy, adoption, abortion) including risks, benefits, and alternatives.

### Professional Obligations

ACOG's position is that abortion is an essential component of comprehensive reproductive healthcare and that access should not be restricted by legislative interference. Providers who object to abortion based on personal beliefs have an obligation to refer patients to willing providers in a timely manner and must provide emergency care regardless of personal objections. ACOG and the Accreditation Council for Graduate Medical Education (ACGME) support routine abortion training as part of OB-GYN residency with an opt-out provision.

<image>Infographic summarizing the ethical principles in reproductive healthcare including autonomy, beneficence, non-maleficence, and justice, with practical examples of how each principle applies to pregnancy termination counseling and care</image>

## Regulatory Landscape

Following the 2022 Dobbs v. Jackson Women's Health Organization decision, abortion regulation varies significantly by state. Providers must be aware of current state-specific laws. Gestational limits, mandatory waiting periods, parental involvement laws, and facility requirements vary widely. Mifepristone can be prescribed via telemedicine in states where medication abortion is legal, and the FDA removed the in-person dispensing requirement in 2023.

## Post-Abortion Contraception

All contraceptive methods can be started immediately after first-trimester abortion. Same-day IUD insertion after aspiration is safe and improves LARC uptake, with expulsion rates comparable to interval insertion for first-trimester procedures. The implant can be placed on the day of the procedure. Ovulation can occur as early as 2 weeks after first-trimester abortion, so contraception should be initiated without delay.

## Clinical Pearls

Medication abortion with mifepristone-misoprostol is safe and effective through 77 days (11 weeks) gestation with a success rate exceeding 95%.

Aspirated tissue should be inspected at the time of procedural abortion to confirm the presence of villi and appropriate volume. Failure to identify villi warrants evaluation for ectopic pregnancy or a failed procedure.

Prophylactic antibiotics reduce post-procedural infection risk and should be administered routinely for surgical abortion.

Same-day LARC insertion after first-trimester abortion is safe and significantly improves contraceptive continuation rates.

Providers have an ethical obligation to refer patients promptly when they are unable or unwilling to provide requested reproductive services.

## References

1. ACOG Practice Bulletin No. 225. *Medication Abortion Up to 70 Days of Gestation*. Obstet Gynecol. 2020;136(4):e31-e47.
2. National Academies of Sciences, Engineering, and Medicine. *The Safety and Quality of Abortion Care in the United States*. Washington, DC: The National Academies Press; 2018.
3. Horvath S, Schreiber CA. Unintended pregnancy, induced abortion, and mental health. Curr Psychiatry Rep. 2017;19(11):77.
4. ACOG Committee Opinion No. 815. *Increasing Access to Abortion*. Obstet Gynecol. 2020;136(6):e107-e115.